UPDATE: BioLineRx (BLRX) Tops Q3 EPS by 2c
Tweet
Share
E-mail
(Updated - November 21, 2017 7:06 AM EST)
BioLineRx (NASDAQ: BLRX) reported Q3 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.09).
For earnings history and earnings-related data on BioLineRx (BLRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- SWBI beats estimates by 71%, GEO nears 52-week high on policy tailwinds
- SAS CEO van der Werff emerges as frontrunner for Air Canada top job - Bloomberg
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
